当前位置:首页 - 行情中心 - 海尔生物(688139) - 财务分析

海尔生物

(688139)

  

流通市值:106.15亿  总市值:106.15亿
流通股本:3.16亿   总股本:3.16亿

海尔生物(688139)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2026年第一季度实现净利润0.80亿元,每股收益0.25元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2026年第一季度最新股东权益470207.45万元,未分配利润224305.89万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2026年第一季度最新总资产585570.73万元,负债115363.27万元。

利润表
报告期2026-03-312025-12-312025-09-302025-06-30
营业总收入652,078,594.242,328,672,376.011,761,188,311.041,195,500,051.78
营业总成本581,544,373.932,111,350,181.831,585,741,477.61,066,058,361.3
其他经营收益
营业利润83,932,443.64266,343,393.47211,839,125.16157,537,694.29
利润总额84,606,427.65264,759,972.83210,184,973.39156,193,043.7
净利润79,989,325.33255,132,280.57202,139,492.05147,213,041.4
每股收益
其他综合收益-9,068.2410,148,619.24297,407.11625,201.66
综合收益总额79,980,257.09265,280,899.81202,436,899.16147,838,243.06
资产负债表
报告期2026-03-312025-12-312025-09-302025-06-30
流动资产:
流动资产合计2,741,389,939.312,658,841,758.772,550,077,650.982,607,094,479.98
非流动资产:
非流动资产合计3,114,317,348.353,132,673,130.463,100,366,771.463,004,985,131.76
资产总计5,855,707,287.665,791,514,889.235,650,444,422.445,612,079,611.74
流动负债:
流动负债合计1,068,487,603.691,085,490,263.29926,292,638.32897,276,443.44
非流动负债:
非流动负债合计85,145,145.7382,829,809.84138,775,837.59156,432,636.53
负债合计1,153,632,749.421,168,320,073.131,065,068,475.911,053,709,079.97
所有者权益(或股东权益):
归属于母公司股东权益合计4,454,048,303.094,375,697,060.094,335,622,713.14,307,982,184.48
股东权益合计4,702,074,538.244,623,194,816.14,585,375,946.534,558,370,531.77
负债和股东权益合计5,855,707,287.665,791,514,889.235,650,444,422.445,612,079,611.74
现金流量表
报告期2026-03-312025-12-312025-09-302025-06-30
经营活动产生的现金流量:
经营活动现金流入小计601,271,685.332,537,076,116.521,759,634,618.611,199,365,522.61
经营活动现金流出小计589,594,457.982,269,181,743.341,676,991,482.291,163,725,455.85
经营活动产生的现金流量净额11,677,227.35267,894,373.1882,643,136.3235,640,066.76
投资活动产生的现金流量:
投资活动现金流入小计785,218,638.163,978,287,060.953,157,342,428.912,293,110,996.44
投资活动现金流出小计541,678,197.983,961,541,956.243,082,317,227.092,291,615,423.75
投资活动产生的现金流量净额243,540,440.1816,745,104.7175,025,201.821,495,572.69
筹资活动产生的现金流量:
筹资活动现金流入小计5,000,000738,191,461.12558,303,291.65378,868,861.1
筹资活动现金流出小计6,633,468.061,006,927,877.65803,835,135.62594,403,076.26
筹资活动产生的现金流量净额-1,633,468.06-268,736,416.53-245,531,843.97-215,534,215.16
汇率变动对现金及现金等价物的影响-7,434,796.113,199,531.71,655,825.715,555,997.04
现金及现金等价物净增加额246,149,403.3619,102,593.06-86,207,680.12-172,842,578.67
期末现金及现金等价物余额799,956,027.1553,806,623.74448,496,350.56361,861,452.01
补充资料:
现金及现金等价物的净增加额-19,102,593.06--172,842,578.67
最新报告期:2026-05-11
研究机构分析师预测每股收益(元)更新日
2026年2027年2028年
中信证券宋硕,陈竹,曾令鹏0.911.031.162026-05-11
东海证券杜永宏0.911.011.172026-04-14
开源证券余汝意,石启正0.881.021.202026-03-31
中国银河孟熙,程培1.001.221.462026-03-29
国联民生杨芳,张金洋0.840.97--2026-03-01
TOP↑